Overview

Niapsan as Add -on Therapy to Antipsychotic Treatment in First Episode Psychosis

Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to help understand if by adding Niaspan FCT (study drug) to antipsychotic medications will it help maintain or improve cognitve functioning.
Phase:
Phase 3
Details
Lead Sponsor:
Nova Scotia Health Authority
Treatments:
Antipsychotic Agents
Niacin
Nicotinic Acids